BR112018001179A2 - Methods and compositions using bifidobacterium longum to optimize breastfeeding - Google Patents

Methods and compositions using bifidobacterium longum to optimize breastfeeding

Info

Publication number
BR112018001179A2
BR112018001179A2 BR112018001179A BR112018001179A BR112018001179A2 BR 112018001179 A2 BR112018001179 A2 BR 112018001179A2 BR 112018001179 A BR112018001179 A BR 112018001179A BR 112018001179 A BR112018001179 A BR 112018001179A BR 112018001179 A2 BR112018001179 A2 BR 112018001179A2
Authority
BR
Brazil
Prior art keywords
optimize
breastfeeding
compositions
methods
bifidobacterium longum
Prior art date
Application number
BR112018001179A
Other languages
Portuguese (pt)
Inventor
Rochat Florence
Bergonzelli Degonda Gabriela
Antonius Johannes Schmitt Jeroen
HAUSER Jonas
ALVES NUNES Tiago
Marquardt Valerie
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112018001179A2 publication Critical patent/BR112018001179A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

a presente invenção refere-se a b. longum atcc baa-999 ou uma composição que compreende b. longum atcc baa-999 para uso em um indivíduo para; apoiar o início da amamentação e/ou otimizar a duração da amamentação e/ou otimizar a qualidade e/ou a quantidade de leite materno e/ou evitar ou tratar distúrbio emocional periparto e/ou regular a atividade da amígdala e/ou regular a liberação de crh e evitar ou tratar os efeitos negativos de distúrbio emocional periparto na prole de indivíduos.The present invention relates to b. longum atcc baa-999 or a composition comprising b. atum baa-999 longum for use in an individual for; support breastfeeding initiation and / or optimize breastfeeding duration and / or optimize breast milk quality and / or quantity and / or prevent or treat peripartum emotional disorder and / or regulate amygdala activity and / or regulate release to prevent or treat the negative effects of peripartum emotional disorder on the offspring of individuals.

BR112018001179A 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding BR112018001179A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562212148P 2015-08-31 2015-08-31
US201562220408P 2015-09-18 2015-09-18
US201562220414P 2015-09-18 2015-09-18
US201562236639P 2015-10-02 2015-10-02
US201562236638P 2015-10-02 2015-10-02
PCT/EP2016/070496 WO2017037105A1 (en) 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding

Publications (1)

Publication Number Publication Date
BR112018001179A2 true BR112018001179A2 (en) 2018-09-11

Family

ID=56852263

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001179A BR112018001179A2 (en) 2015-08-31 2016-08-31 Methods and compositions using bifidobacterium longum to optimize breastfeeding

Country Status (7)

Country Link
EP (1) EP3344269A1 (en)
CN (1) CN107980002A (en)
BR (1) BR112018001179A2 (en)
CA (1) CA2994352A1 (en)
MX (1) MX2018002032A (en)
PH (1) PH12018500117A1 (en)
WO (1) WO2017037105A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201924696A (en) 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 Maternal supplement
CN111165828A (en) * 2020-03-24 2020-05-19 西安交通大学医学院第一附属医院 Composition and health food for promoting milk secretion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101095698B (en) * 2006-06-26 2010-12-01 青岛东海药业有限公司 Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease
EP2110028A1 (en) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum and hippocampal BDNF expression
EP2352393A1 (en) * 2008-11-03 2011-08-10 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
EP2289527B1 (en) * 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
CA2779418C (en) * 2009-11-11 2018-03-20 Alimentary Health Limited Probiotic bifidobacterium strain
WO2015090349A1 (en) * 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants

Also Published As

Publication number Publication date
EP3344269A1 (en) 2018-07-11
CN107980002A (en) 2018-05-01
MX2018002032A (en) 2018-04-13
WO2017037105A1 (en) 2017-03-09
CA2994352A1 (en) 2017-03-09
PH12018500117A1 (en) 2018-07-23

Similar Documents

Publication Publication Date Title
GT201700072A (en) COMPOSITIONS AND METHODS OF USE TO TREAT METABOLIC DISORDERS
CL2020002019A1 (en) Compositions to modulate the expression of c9orf72. (divisional request 201803582)
CL2017000201A1 (en) Compositions and methods of use to treat metabolic disorders
BR112018004532A2 (en) use of pasteurized akkermansia for the treatment of metabolic disorders
ES2692773T3 (en) Treatments for fibrosis
BR112017000313A2 (en) system for providing a buccal treatment composition, buccal treatment composition, method for administering a buccal treatment composition
BR112015015891A8 (en) SOLID SOLUTION PHARMACEUTICAL COMPOSITION, AND, USE OF A PHARMACEUTICAL COMPOSITION
BR112018074454A2 (en) compositions and methods of using nintedanib to treat eye disease with abnormal neovascularization
BR112017003346A2 (en) pyrazolopyridine derivatives, their uses, and pharmaceutical composition
BR112017005209A2 (en) rorc2 methyl and trifluoromethyl substituted pyrrolopyridine modulating compounds and their use
EA201790787A1 (en) REDUCTION OF VISCOSITY OF PHARMACEUTICAL COMPOSITIONS
MX2018001849A (en) Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances.
AR102085A1 (en) NUTRITIONAL COMPOSITION FOR THE GASTROINTESTINAL ENVIRONMENT FOR THE PROVISION OF AN IMPROVED METABOLIC PROFILE AND MICROBIOMA
PH12019500949A1 (en) Ror-gamma modulators
PH12016501072B1 (en) Composition for oral delivery of bioactive agents
SV2018005731A (en) PIPERIDINS REPLACED WITH HALO AS MODULATORS OF THE OREXINE RECEIVER
BR112017005200A2 (en) composition, edible formulation, and method for increasing serum iron in a mammal in need thereof.
BR112018069682A2 (en) treatment methods for cholestatic and fibrotic diseases
UY36173A (en) METHOD OF TREATMENT OF DISEASES RELATED TO THE INDICATABLE FACTOR FOR HYPOXIA
MX2018005158A (en) Compounds for treatment of hypoproliferative disorders.
BR112018001179A2 (en) Methods and compositions using bifidobacterium longum to optimize breastfeeding
BR112018000252A2 (en) pharmaceutical methods and compositions for enhancing nk cell elimination activities
BR112017009358A2 (en) therapeutic t-peptide specific immunotherapy for use in the treatment of brain metastasis of a hla-2 positive patient
BR112016004904A8 (en) liver x receptor (lxr) modulators, pharmaceutical composition, their uses and method to modulate lxr activity
MX2017004986A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 for ocular therapies.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.